Research-related news and stories from PHSA, from all programs and services.
(June 11, 2024)
Researchers at BC Children’s Hospital Research Institute have been working for over a decade on a study that uses genomics to identify treatments specific to an individual child’s cancer.
Read about the study
(May 28, 2024)
Prince George celebrated a significant milestone in early 2024: the first time that a systemic therapy clinical trial has been offered in northern B.C. to people with cancer.
Read about the systemic therapy clinical trial
(May 13, 2024)
Dr. Sean Barbour, BC Renal Glomerulonephritis Registry's Medical Lead, partnered with international researchers to lead a small, Phase 2 clinical trial of cemdisiran.
Read about the cemdisiran trial
(May 10, 2024)
Dr. Mohammad Atiquzzaman and colleagues from BC Renal found the Kidney Failure Risk Equation could be used to support better timing of vascular access point creation, which could lead to increased patient quality of life and improved outcomes.
Read about the Kidney Failure Risk Equation study
(May 10, 2024)
An international collaboration, including researchers from BC Renal and UBC, found substantial regional differences in hemoglobin values in individuals with chronic kidney disease.
Read about the hemoglobin study
(April 30, 2024)
A new pan-Canadian analysis involving BC Children's Research showed a sharp increase in the cost of eating disorders in children and youth, comparing the periods before and during the COVID-19 pandemic. Read about the analysis
(April 18, 2024)
Dr. Cheryl Peters and team will be speaking with Canadians and conducting research to better understand how online misinformation about cancer can affect people's health.
Read about the cancer misinformation study
(April 9, 2024)
Dr. Alexander Beristain’s lab at BC Children's Research is investigating two state-of-the-art stem cell-based tools that model a human placenta to find answers that can positively impact children’s health.
Read about the tools
(March 28, 2024)
Dr. Poul Sorensen found that the environment around a tumour may cause inflammation and suppress the immune system, affecting treatment of solid tumours with immunotherapy.
Read about the immunotherapy study
More research news & stories